Quidel Corporation (QDEL): Price and Financial Metrics


Quidel Corporation (QDEL): $89.70

-1.76 (-1.92%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

QDEL POWR Grades

  • QDEL scores best on the Value dimension, with a Value rank ahead of 87.78% of US stocks.
  • QDEL's strongest trending metric is Growth; it's been moving down over the last 177 days.
  • QDEL's current lowest rank is in the Momentum metric (where it is better than 1.11% of US stocks).

QDEL Stock Summary

  • QDEL's went public 30.94 years ago, making it older than 83.37% of listed US stocks we're tracking.
  • With a year-over-year growth in debt of 1,896.85%, QUIDELORTHO CORP's debt growth rate surpasses 98.7% of about US stocks.
  • Revenue growth over the past 12 months for QUIDELORTHO CORP comes in at 62.29%, a number that bests 86.1% of the US stocks we're tracking.
  • If you're looking for stocks that are quantitatively similar to QUIDELORTHO CORP, a group of peers worth examining would be SANW, LFUS, JMIA, ISPC, and CEMI.
  • Visit QDEL's SEC page to see the company's official filings. To visit the company's web site, go to www.quidel.com.

QDEL Valuation Summary

  • In comparison to the median Healthcare stock, QDEL's price/earnings ratio is 68.78% lower, now standing at 6.9.
  • Over the past 243 months, QDEL's price/earnings ratio has gone down 37.1.

Below are key valuation metrics over time for QDEL.

Stock Date P/S P/B P/E EV/EBIT
QDEL 2023-01-30 1.9 1.2 6.9 7.4
QDEL 2023-01-27 1.9 1.2 7.0 7.5
QDEL 2023-01-26 1.9 1.2 7.0 7.5
QDEL 2023-01-25 1.9 1.2 7.0 7.5
QDEL 2023-01-24 1.9 1.2 7.1 7.5
QDEL 2023-01-23 2.0 1.3 7.4 7.8

QDEL Growth Metrics

    The year over year cash and equivalents growth rate now stands at 30.02%.
  • Its year over year net cashflow from operations growth rate is now at -37.49%.
  • The 2 year net cashflow from operations growth rate now stands at 343.2%.
Over the past 49 months, QDEL's revenue has gone up $2,531,739,000.

The table below shows QDEL's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-09-30 3,036.326 1,037.277 809.753
2022-06-30 2,762.262 1,124.036 1,006.305
2022-03-31 2,325.472 721.384 1,006.078
2021-12-31 1,698.551 805.869 704.226
2021-09-30 1,870.887 923.623 883.039
2021-06-30 1,837.209 917.019 899.555

QDEL's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • QDEL has a Quality Grade of B, ranking ahead of 85.03% of graded US stocks.
  • QDEL's asset turnover comes in at 1.046 -- ranking 21st of 680 Pharmaceutical Products stocks.
  • SYRS, ONVO, and SESN are the stocks whose asset turnover ratios are most correlated with QDEL.

The table below shows QDEL's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 1.046 0.813 1.894
2021-03-31 1.203 0.825 2.292
2020-12-31 1.314 0.812 2.053
2020-09-30 0.980 0.739 1.094
2020-06-30 0.705 0.663 0.537
2020-03-31 0.625 0.614 0.329

QDEL Price Target

For more insight on analysts targets of QDEL, see our QDEL price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $127.75 Average Broker Recommendation 1.8 (Moderate Buy)

QDEL Stock Price Chart Interactive Chart >

Price chart for QDEL

QDEL Price/Volume Stats

Current price $89.70 52-week high $120.61
Prev. close $91.46 52-week low $66.88
Day low $89.44 Volume 394,100
Day high $92.00 Avg. volume 532,457
50-day MA $87.25 Dividend yield N/A
200-day MA $90.08 Market Cap 5.92B

Quidel Corporation (QDEL) Company Bio


Quidel Corporation develops, manufactures, and markets diagnostic testing solutions for applications primarily in infectious diseases, women’s health, and gastrointestinal diseases. The company was founded in 1979 and is based in San Diego, California.


QDEL Latest News Stream


Event/Time News Detail
Loading, please wait...

QDEL Latest Social Stream


Loading social stream, please wait...

View Full QDEL Social Stream

Latest QDEL News From Around the Web

Below are the latest news stories about QUIDELORTHO CORP that investors may wish to consider to help them evaluate QDEL as an investment opportunity.

Top Healthcare Stocks

Top healthcare stocks include Azenta for best value, Neurocrine Biosciences for fastest growth, and Signify Health for most momentum.

Yahoo | January 24, 2023

QuidelOrtho Reports Preliminary Revenue Results for Fourth Quarter and Full Year 2022

SAN DIEGO, January 06, 2023--QuidelOrtho Corporation (Nasdaq: QDEL) (the "Company" or "QuidelOrtho"), a global provider of innovative in vitro diagnostics technologies designed for point-of-care settings, clinical labs and transfusion medicine, today announced preliminary unaudited revenue results for the fourth quarter and full year ended January 1, 2023.

Yahoo | January 6, 2023

Is QuidelOrtho Corporation's (NASDAQ:QDEL) Latest Stock Performance A Reflection Of Its Financial Health?

QuidelOrtho (NASDAQ:QDEL) has had a great run on the share market with its stock up by a significant 19% over the last...

Yahoo | January 3, 2023

These strategies will help QuidelOrtho Corporation (QDEL) succeed

As of Thursday, QuidelOrtho Corporation’s (NASDAQ:QDEL) stock closed at $85.14, up from $82.89 the previous day. While QuidelOrtho Corporation has overperformed by 2.71%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, QDEL fell by -33.48%, with highs and lows ranging from $136.96 to $66.88, whereas the […]

US Post News | December 30, 2022

QuidelOrtho to Present at the J.P. Morgan Healthcare Conference

SAN DIEGO, December 28, 2022--QuidelOrtho Corporation (Nasdaq: QDEL) ("QuidelOrtho"), a global provider of innovative in vitro diagnostics technologies designed for point-of-care settings, clinical labs and transfusion medicine, announced today that members of its management team are scheduled to participate in the 41st Annual J.P. Morgan Healthcare Conference in San Francisco beginning on January 9, 2023, with a presentation scheduled for 9:00 a.m. PST / 12:00 p.m. EST.

Yahoo | December 28, 2022

Read More 'QDEL' Stories Here

QDEL Price Returns

1-mo -1.18%
3-mo 1.30%
6-mo 3.74%
1-year -9.27%
3-year 15.43%
5-year 102.67%
YTD 4.70%
2022 -36.54%
2021 -24.86%
2020 139.44%
2019 53.69%
2018 12.62%

Continue Researching QDEL

Here are a few links from around the web to help you further your research on Quidel Corp's stock as an investment opportunity:

Quidel Corp (QDEL) Stock Price | Nasdaq
Quidel Corp (QDEL) Stock Quote, History and News - Yahoo Finance
Quidel Corp (QDEL) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.7191 seconds.